Retrieve available abstracts of 13 articles: HTML format
Single Articles
March 2025
TAKAHASHI EA, Sista AK, Addison D, Bikdeli B, et al Disparities in Current Pulmonary Embolism Management and Outcomes: A Scientific
Statement From the American Heart Association.
Circulation. 2025 Mar 20. doi: 10.1161/CIR.0000000000001306. PubMedAbstract available
February 2025
RAO SV, Gutierrez JAT A Win for Clinical Evidence: The First Head-to-Head Trial of Interventional
Strategies for the Treatment of Pulmonary Embolism.
Circulation. 2025;151:274-276. PubMed
November 2024
YAMASHITA Y, Morimoto T, Muraoka N, Shioyama W, et al Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute
Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical
Trial (ONCO PE Trial).
Circulation. 2024 Nov 18. doi: 10.1161/CIRCULATIONAHA.124.072758. PubMedAbstract available
October 2024
JABER WA, Gonsalves CF, Stortecky S, Horr S, et al Large-bore Mechanical Thrombectomy Versus Catheter-directed Thrombolysis in the
Management of Intermediate-risk Pulmonary Embolism: Primary Results of the
PEERLESS Randomized Controlled Trial.
Circulation. 2024 Oct 29. doi: 10.1161/CIRCULATIONAHA.124.072364. PubMedAbstract available
DELCROIX M, Pepke-Zaba J, D'Armini AM, Fadel E, et al Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy,
Balloon Pulmonary Angioplasty, and Medical Therapy.
Circulation. 2024;150:1354-1365. PubMedAbstract available
September 2024
ROSENFIELD K, Bowers TR, Barnett CF, Davis GA, et al Standardized Data Elements for Patients With Acute Pulmonary Embolism: A
Consensus Report from the Pulmonary Embolism Research Collaborative.
Circulation. 2024 Sep 12. doi: 10.1161/CIRCULATIONAHA.124.067482. PubMedAbstract available
SINGH S, Kumar P, Padwad YS, Jaffer FA, et al Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview
of an Emerging Therapeutic Approach.
Circulation. 2024;150:884-898. PubMedAbstract available
June 2024
Correction to: Status and Future Directions for Balloon Pulmonary Angioplasty in
Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension:
A Scientific Statement From the American Heart Association.
Circulation. 2024;149:e1412. PubMed
March 2024
AGGARWAL V, Giri J, Visovatti SH, Mahmud E, et al Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic
Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A
Scientific Statement From the American Heart Association.
Circulation. 2024 Mar 7. doi: 10.1161/CIR.0000000000001197. PubMedAbstract available
December 2023
OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al Arterial Thromboembolism in Patients With Atrial Fibrillation and
CHA(2)DS(2)-VASc 1: A Nationwide Study.
Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477. PubMedAbstract available
November 2023
GOTO S, Goto S Clinical Course of Isolated Distal Venous Thromboembolism in Patients With Active
Cancer in a Nation With an Overall Low Risk of Thrombosis.
Circulation. 2023;148:1677-1679. PubMed
HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in
Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528. PubMed
March 2023
LASSEN MCH, Modin D, Skaarup KG, Johansen ND, et al Risk of Incident Thromboembolic and Ischemic Events After COVID-19 Vaccination
Compared With SARS-CoV-2 Infection.
Circulation. 2023;147:843-845. PubMed